A Serum Antigen (Australia Antigen) in Down's Syndrome, Leukemia, and Hepatitis
Authors: BARUCH S. BLUMBERG
Journal: Annals of Internal Medicine (1967)

Article1 May 1967A Serum Antigen (Australia Antigen) in Down's Syndrome, Leukemia, and HepatitisBARUCH S. BLUMBERG, M.D., D.PHIL., F.A.C.P., BETTY JANE S. GERSTLEY, M.D., DAVID A. HUNGERFORD, PH.D., W. THOMAS LONDON, M.D., ALTON I. SUTNICK, M.D., F.A.C.P.BARUCH S. BLUMBERG, M.D., D.PHIL., F.A.C.P., BETTY JANE S. GERSTLEY, M.D., DAVID A. HUNGERFORD, PH.D., W. THOMAS LONDON, M.D., ALTON I. SUTNICK, M.D., F.A.C.P.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-66-5-924 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptWe have previously reported the presence of an isoantigen of human sera, rare or absent in normal U. S. and northern European populations but relatively common in patients with leukemia (1, 2). The "new" isoantigen has been called "Australia antigen" because it was first found in the serum of an Australian aborigine. It appears to be different from the low-density lipoprotein isoantigen system first described in our laboratory (3-5). Hemophilia patients and others who have received multiple transfusions may develop precipitating isoantibodies against Australia antigen. These precipitating isoantibodies react with a protein in the blood of some normal and some...References1. BLUMBERG BS: Polymorphism of serum proteins and the development of iso-precipitins in transfused patients. Bull. N. Y. Acad. Med. 40: 377, 1964. MedlineGoogle Scholar2. BLUMBERGALTERVISNICH BSHJS: A "new" antigen in leukemia sera. JAMA 191: 541, 1965. CrossrefMedlineGoogle Scholar3. ALLISONBLUMBERG ACBS: An isoprecipitin reaction distinguishing human serum-protein types. Lancet 1: 634, 1961. CrossrefMedlineGoogle Scholar4. BLUMBERGALLISON BSAC: Studies on the isoprecipitin-determined human serum polymorphism, in Proceedings of the International Congress on Human Genetics, 2nd (Rome). Istituto Gregorio Mendel, Rome, 1961, pp. 733-736. Google Scholar5. BLUMBERGDRAYROBINSON BSSJC: Antigen polymorphism of a low-density betalipoprotein. Allotypy in human serum. Nature (London) 194: 656, 1962. CrossrefMedlineGoogle Scholar6. ALTERBLUMBERG HJBS: Studies on a "new" human isoprecipitin system (Australia antigen). Blood 27: 297, 1966. CrossrefMedlineGoogle Scholar7. MELARTINBLUMBERG LBS: Production of antibody against "Australia antigen" in rabbits. Nature (London) 210: 1340, 1966. CrossrefMedlineGoogle Scholar8. BLUMBERGMELARTINGUINTOWERNER BSLRAB: Family studies of a "new" human serum isoantigen system (Australia antigen). Amer. J. Hum. Genet. 18: 594, 1966. MedlineGoogle Scholar9. BLUMBERGALTER BSHJ: Precipitating antibodies against a serum protein ("Australia antigen") in the serum of transfused hemophilia patients (abstract). J. Clin. Invest. 44: 1029, 1965. Google Scholar10. BLUMBERG BS: An inherited serum isoantigen in leukemia and Down's syndrome (abstract). J. Clin. Invest. 45: 988, 1966. Google Scholar11. MILLER RW: Radiation, chromosomes and viruses in the etiology of leukemia. Evidence from epidemiologic research. New Eng. J. Med. 271: 30, 1964. CrossrefMedlineGoogle Scholar12. LIDDLESEEGMILLERLASTER LLEL: The enzymatic spectrophotomotic method for determination of uric acid. J. Lab. Clin. Med. 54: 903, 1959. MedlineGoogle Scholar13. MELLMANOSKITEDESCOMACIERO-COELHOHARRIS WJFATAAH: Leucocyte enzymes in Down's syndrome. Lancet 2: 674, 1964. CrossrefMedlineGoogle Scholar14. HUTNERBACHROSS SHMKGJ: A familial form of aplastic anemia supposed to be hereditary; due to a recessive gene. J. Protozool. 3: 101, 1956. CrossrefGoogle Scholar15. BLUMBERGRIDDELL BSNM: Inherited antigenic difference in human serum beta-lipoproteins. A second antiserum. J. Clin. Invest. 42: 867, 1963. CrossrefMedlineGoogle Scholar16. PREERPREER JRLB: Gel diffusion on the antigens of isolated components of Paramecium. J. Protozool. 6: 88, 1959. CrossrefGoogle Scholar17. HUNGERFORD DA: Leucocytes cultured from small inocula of whole blood and the preparation of metaphase chromosomes by treatment with hypotonic KCl. Stain Techn. 40: 333, 1965. CrossrefMedlineGoogle Scholar18. SNEDCOR GW: Statistical Methods. Iowa State University Press, Ames, Iowa, 1962, p. 534. Google Scholar19. BLUMBERGMELARTIN BSL: Conjectures on inherited susceptibility to lepromatous leprosy. Int. J. Leprosy 34: 60, 1966. Google Scholar20. BLUMBERGMELARTINLECHATGUINTO BSLMRA: Studies on leprosy and Australia antigen. JAMA, March 1967. MedlineGoogle Scholar21. LEJEUNETURPINGAUTIER JRM: Le mongolisme, premier exemple d'aberration autosomique humaine. Ann. Genet. (Paris) 1: 41, 1959. Google Scholar22. NAIMANOSKIMELLMAN JLFAWJ: Phosphokinase activity of erythrocytes in mongolism. Lancet 1: 821, 1965. CrossrefMedlineGoogle Scholar23. MERTZFULLERCONCON ETRWJM: Serum uric acid in young mongoloids. Science 141: 535, 1963. CrossrefMedlineGoogle Scholar24. STOLLERCOLLMAN ARD: Incidence of infectious hepatitis followed by Down's syndrome nine months later. Lancet 2: 1221, 1965. CrossrefMedlineGoogle Scholar25. MELLALANG BDJ: Leucocyte mitosis: suppression in vitro associated with acute infectious hepatitis. Science 155: 80, 1967. CrossrefMedlineGoogle Scholar26. FAILKOWUCHIDAHECHTMOTULSKY PJIFAG: Increased frequency of thyroid auto-antibodies in mothers of patients with Down's syndrome. Lancet 2: 868, 1965. CrossrefMedlineGoogle Scholar27. ROBINSONPUCK ATT: Sex chromatin in newborns; presumptive evidence for external factors in human nondisjunctions. Science 148: 83, 1965. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: BARUCH S. BLUMBERG, M.D., D.PHIL., F.A.C.P.; BETTY JANE S. GERSTLEY, M.D.; DAVID A. HUNGERFORD, PH.D.; W. THOMAS LONDON, M.D.; ALTON I. SUTNICK, M.D., F.A.C.P.Affiliations: Philadelphia, PennsylvaniaFrom the Institute for Cancer Research, Fox Chase, Philadelphia, Pa.This study was supported by research grants CA-06551, CA-08069, and FR-05539, the National Cancer Institute, the National Institutes of Health, Bethesda, Md.Requests for reprints should be addressed to Baruch S. Blumberg, M.D., The Institute for Cancer Research, 7701 Burholme Ave., Fox Chase, Philadelphia, Pa. 19111. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byATP5B Is an Essential Factor for Hepatitis B Virus EntryHBV cccDNA─A Culprit and Stumbling Block for the Hepatitis B Virus Infection: Its Presence in Hepatocytes Perplexed the Possible Mission for a Functional CureHepatitis Viruses: Hepatitis B and Hepatitis DViral hepatitis: Milestones, unresolved issues, and future goalsHBsAg, Subviral Particles, and Their Clearance in Establishing a Functional Cure of Chronic Hepatitis B Virus InfectionInterferon-Driven Immune Dysregulation in Down Syndrome: A Review of the EvidenceInsights into the genetic diversity, recombination, and systemic infections with evidence of intracellular maturation of hepadnavirus in catsBibliometric analysis of the 100 most-cited articles in the field of hepatologyBibliometric analysis of the 100 most-cited articles in the field of hepatologyThe Discovery of Hepatitis Viruses: Agents and DiseaseHepatitis AIn Vitro Systems for Studying Different Genotypes/Sub-Genotypes of Hepatitis B Virus: Strengths and LimitationsNon-B, Non-C Viral HepatitisHepatitis B Virus Infection: OverviewOncogenic VirusesImpact of length of replication competent genome of hepatitis B virus over the differential antigenic secretionHBV cccDNA and Its Potential as a Therapeutic TargetRole of HBsAg Testing in the Management of Patients with Chronic HBVPrix Nobel et histoire de la transfusion sanguineWorld Hepatitis Day 2019 – Bringing Medical Advances to Every ManAnalysis of clinical characteristics and S gene sequences in chronic asymptomatic HBV carriers with low-level HBsAgFrom B to Non-B to C: The Hepatitis C Virus in Historical PerspectiveGlobal Epidemiology of Acute Viral Hepatitis A–ERole of tenofovir alafenamide (TAF) in the treatment and prophylaxis of HIV and HBV infectionsElimination of Viral Hepatitis and an Update on Blood Safety TechnologyHepatitis B VaccinesEradicating hepatitis B virus: The critical role of preventing perinatal transmissionHepatitis A and EHepatitis B VirusesEvolution in Our Understanding of Hepatitis B Virus Virology and ImmunologyStrategies for Human Tumor Virus Discoveries: From Microscopic Observation to Digital Transcriptome SubtractionHepatitis B: 50 years after the discovery of Australia antigenChronic hepatitis B: A wave of new therapies on the horizonMolecular biology of hepatitis B virus infectionThe Laboratory Woodchuck (Marmota monax)Explorer, Nobel Laureate, Astrobiologist: Things You Never Knew about Barry BlumbergFungal Expression Systems for Vaccine ProductionEASL Recognition Awardee for 2014: Prof. Tilman SauerbruchDoes low-dose prolonged steroid therapy affect the natural history of chronic hepatitis C?Hepatitis B Virus Replication, Liver Disease, and Hepatocellular CarcinomaInfections with Multiple Hepatotropic VirusesHepatitis Viruses: Hepatitis B and Hepatitis DSurveillance and SeroepidemiologyNatural history of chronic hepatitis B: Phases in a complex relationshipHistoria de la hepatología en CataluñaFocusMortality and Morbidity Among Military Personnel and Civilians During the 1930s and World War II From Transmission of Hepatitis During Yellow Fever Vaccination: Systematic ReviewThe Natural Course of Chronic Hepatitis B Virus Infection and Its ManagementHepatitis B vaccinesImmunological Memory: Ingenuity and SerendipityPrevalence of hepatitis B virus infection among blood donors at the Tamale Teaching Hospital, Ghana (2009)Clinical trials and their translation in hepatology: Past, present, and futureThe diversity of human cancer virusesViral Hepatitis—The Silent KillerTwo decades of hepatitis B vaccination in mentally retarded patients: Effectiveness, antibody persistence and duration of immune memoryViral infections and human cancers: the legacy of Denis BurkittViruses and Cancer: A Historical Perspective – HBV and Prevention of a CancerHepadnaviruses and Hepatocellular CarcinomaEpidemiology of Chronic HCVThe Australia antigen and role of the late Philadelphia general hospital in reducing post-transfusion hepatitis and sequelaeHepatitis B surface antigen confirmatory testing for diagnosis of hepatitis b virus infection in TaiwanA 50-year experience with autoimmune hepatitis: and where are we now?Milestones and perspectives in viral hepatitis BView and review on viral oncology researchTelbivudine: an effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responsesChronic Hepatitis B: Past, Present, and FutureHistórico das hepatites viraisIdentification of natural recombination in duck hepatitis B virusUnprecedented Opportunities and Promise for Cancer Prevention ResearchHepatitis VirusesHepatitis BHepatitis BAcute Viral HepatitisAdvances in viral hepatitis: 50âyears of Australian gastroenterologyCancer Prevention: From 1727 to Milestones of the Past 100 YearsCancer Prevention Research: Back to the FutureInnovative vaccine production technologies: The evolution and value of vaccine production technologiesAn Experience of the Use of Anti-HBc and Anti-HBs for Blood Donor Screening Tests at a Tertiary Hospital Blood Center in KoreaThe History of Tumor VirologyRecent data on treatment of chronic hepatitis B with nucleos(t)ide analoguesFractionated productsNobel Prize to Baruch Blumberg for the discovery of the aetiology of hepatitis BHepatitis B vaccinesHepatitis B vaccines: accomplishments, shortcomings, and future developmentsHistorical reflections on autoimmune hepatitisViral Hepatitis: Historical Perspectives from the 20th to the 21st CenturyDNA viruses in human cancer: An integrated overview on fundamental mechanisms of viral carcinogenesisInfectious Disease Testing: Basic Principles and Practical AspectsHepatitis A, B, and Non-A, Non-B, Non-C VirusesHepatitis B, Hepatitis C, and Hepatocellular CarcinomaComparative Immunogenicity of a Genetically Derived and a Plasma Pooled Hepatitis B Vaccine in Normal Adult VolunteersPrevalence of hepatitis B and C in the maternity department of a Greek district hospitalCell Culture and Animal Models of Viral Hepatitis. Part I: Hepatitis BHepatocellular CarcinomaHistory of viral hepatitisA evolução do conhecimento sobre as hepatites virais na região amazônica: da epidemiologia e etiologia à prevençãoCritical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virusTreatment of chronic hepatitis B: current challenges and future directionsWaldenström J. Leber. Blutproteine und Nahrungseiweiss [Deutsch Z Verdau Stoffwechselkr 1950;15:113–119]Overview: Past and future of immunologic intervention in the pathogenesis, prophylaxis and therapeusis of hepatitis BThe cutaneous manifestations of viral hepatitisViral Hepatitis in the Compromised HostHepatitis Viruses: The Natural History of InfectionGerms, Gels and Genomes. A Personal Recollection of 30 Years in Blood Safety TestingHepatitis B VirusesHepatitis C: A review and updateThe Genomics and Genetics of Human Infectious Disease SusceptibilityViral hepatitis and primates: historical and molecular analysis of human and nonhuman primate hepatitis A, B, and the GB-related virusesOverview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applicationsAnimal Models of Hepadnavirus Associated Hepatocellular CarcinomaHepatitis C: A review and updateHepatitis Viruses and Blood TransfusionThe Woodchuck Model of Hepatitis B Virus InfectionHEPATITIS CFIFTY LANDMARK DISCOVERIES IN GASTROENTEROLOGY DURING THE PAST 50 YEARSCURRENT UPDATE OF PEDIATRIC HEPATITIS VACCINE USETHERAPEUTIC VACCINES FOR CHRONIC HEPATITIS B INFECTIONDiscovery of non-A, non-B hepatitis and identification of its etiologyViruses in human cancersViruses in human cancersANIMAL MODELS OF HEPATITIS B VIRUS INFECTIONUpdate on Diagnosis, Management, and Prevention of Hepatitis B Virus InfectionIntroductionNew insights into the Far Eastern pattern of mortalityPREFACEPharmacokinetics of 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)uracil in woodchucks1a Virus transmission by allogenous blood and blood componentsSurveillance and SeroepidemiologyHepatitis B epidemiology and cultural practices in Amerindian populations of Amazonia: The Tupí-Mondé and the Xavánte from BrazilPrevalence of hepatitis B virus markers in several institutions for the mentally handicapped in the autonomous community of MadridMolecular Biology of Virally-Induced Cell Transformation and TumorigenesisHepatitis C virus and liver diseasesThe carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liverViral Hepatitis in the Compromised HostHepatitis B virus precore and core gene mutations in chronic hepatitis B and hepatocellular carcinoma patientsCausation and Acute Viral DiseasesHepatitis A: therapeutic approaches, prevention and controlA Comparison of Human Immunodeficiency Virus (HIV) Seropositivity and Hepatitis B Surface Antigenemia (HBs Ag) among the Same Group of Apparently Healthy Pregnant Women in Lagos, Nigeria: A Preliminary ReportThe role of hepatitis B virus in the development of primary hepatocellular carcinoma: Part IHepatitis B screening and immunization for people with a mental handicap in Southampton: costs and benefitsViral exanthemsVaccines in Perspective: Human Hepatitis B Vaccines, the First Subunit and Recombinant Viral VaccinesPublic health service interagency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis CChronic Posttransfusion Non-A, Non-B Hepatitis and Autoimmune Chronic Active Hepatitis - Aspects on Treatment, Prognosis and Relation to Hepatitis C VirusSurveillance and SeroepidemiologyThe prevalence of Hepatitis B surface antigen and antibody in home-reared individuals with down syndromeDetection of Mycobacterium leprae antigens in the sera of leprosy patients by sandwich immunoradiometric assay using monoclonal antibodiesApproach to Immunization in the Immunosuppressed HostHépatite virale de type CHepatitis B infection and renal disease: Clinical, immunopathogenetic and therapeutic considerationsEpidemiology of chronic viral hepatitis in the mediterranean area: Present status and trendsViral HepatitisProtective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clientsHepatitis B and Workers in Institutions for the Mentally Retarded: Risk of Infection for Staff in Patient CareSurveillance and SeroepidemiologyThe Serology of Viral Hepatitis Making Sense out of Alphabet SoupHepatitis B and A vaccinesHaemodialysis: A Historical ReviewBlood transfusion and hepatitis: still a threat?Vaccines Produced by Conventional Means to Control Major Infectious Diseases of Man and AnimalsBiochemical Detection of Hepatitis B Virus ConstituentsLOW PREVALENCE OF HEPATITIS B IN MENTAL HANDICAP HOSPITALPurity, antigenicity and immunogenicity of the hepatitis B surface antigen purified by five different methodsTransfusion-Associated Hepatitis B: Past and PresentHepatitis B and AIDS and the promise for their control by vaccinesViral HepatitisHepatitis B in a hospital for the mentally subnormal in South WalesHepadnaviridae: Hepatitis B Virus and the Delta VirusViral Hepatitis in the Compromised HostViral Hepatitis in the Compromised HostLabormedizinische Diagnostik von Lebererkrankungen: Neue ErkenntnisseHepatitis B Viral InfectionDown's syndrome and leukemia: Epidemiology, genetics, cytogenetics and mechanisms of leukemogenesisInfectious Hepatitis in Dialysis PatientsLong-term follow-up of the immune response to hepatitis B vaccine in patients with Down's syndromeYeast recombinant hepatitis B vaccineWhat is the effect of a cytomegalovirus infection when superimposed on HBsAg-positive chronic hepatitis?Chronic Hepatitis B: Impact of Hepatitis D Virus Superinfection and the Hepatitis B E-System on Histological Outcome, and Correlation of the Hepatitis B E-System to HBV-DNA in SerumTowards the control of hepatitis B: An historical review`Hepatitis B Virus, Iron and Iron-Binding ProteinsDetection of both hepatitis B e antigen and antibody in a single assay using monoclonal reagentsThe Daedalus Effect: Changes in Ethical Questions Relating to Hepatitis B VirusBARUCH S. BLUMBERG, M.D., RENÉE C. FOX, Ph.D.Prevalence survey for hepatitis B in high-risk university hospital employeesAutoimmune Diseases of the Liver: Chronic Active Hepatitis and Primary Biliary CirrhosisChapter 16 Hepatitis virus infectionsAustralia Antigen and the Prevention of Posttransfusion HepatitisEPIDEMIOLOGIC LESSONS FROM VIRAL HEPATITIS BHLA, Blood Transfusion and the Immune SystemDetection of the Relation between the Australia Antigen and Hepatitis B VirusHepatitis B Vaccination in Down's Syndrome and Other Mentally Retarded PatientsViral hepatitis and the anaesthetistViral HepatitisSurveillance and SeroepidemiologyThe Development of the Hepatitis B VaccineKeynote Address: The Australia Antigen StoryAssays for Hepatitis B VirusViral Disease Models in PrimatesHepatitis B in seven hospitals for the mentally handicappedHepatitis B vaccineThe preparation and safety of hepatitis B vaccineImmune responses to hepatitis B vaccine in the mentally retardedNon-A, non-B hepatitis. Serological, clinical, morphological and prognostic aspectsDermatologic manifestations of hepatitis B virus infectionVaccination Against Hepatitis B Virus: Past and Future ProblemsHaemodialysis: A Historical ReviewSymposium on Vaccination against Hepatitis B: Excerpts from a Pre-Congress Meeting in Connection with the 17th Meeting of the European Association for the Study of the Liver (EASL). Goteborg, Sweden, September 9, 1982Positions in Infectious and Parasitic Diseases: Excerpts from the 8th IFIPD Congress Stockholm, June 8–11, 1982DEMONSTRATION OF PREVIOUSLY UNDETECTED HEPATITIS B VIRAL DETERMINANTS IN AN AUSTRALIAN ABORIGINAL POPULATION BY MONOCLONAL ANTI-HBs ANTIBODY RADIOIMMUNOASSAYSHepatitis-Associated Markers in the American Red Cross Volunteer Blood Donor PopulationViral HepatitisSurveillance and SeroepidemiologyHepatitis B Virus VaccineHepatitis vaccinesRemoval of hepatitis B virus from a concentrate of coagulation factors II, VII, IX and X by hydrophobic interaction chromatographyHepatitis A: Aspects on Prophylaxis and a Comparison with Hepatitis B and Hepatitis Non-A, Non-B on Epidemiology and PrognosisThe hepatitis A virus infectionEpidemiology of hepatitis B infection in Liberian infantsSerum Alanine Aminotransferase of Donors in Relation to the Risk of Non-A,Non-B Hepatitis in RecipientsPrevalence of antibodies to hepatitis a antigen in sera from patients with hematological malignanciesStatus and significance of testing for hepatitis B surface antigen and surface antibodyPolyarteritis NodosaHepatitis-Associated Markers in the American Red Cross Volunteer Blood Donor PopulationHepatitis: A Review of the Disease and its Significance to DentistrySerological Markers of Hepatitis B InfectionType B Hepatitis: Progression to Chronic HepatitisSex differences in response to hepatitis b virusSerological relationship of woodchuck hepatitis virus to human hepatitis B virusThe growth of knowledge about a disease: HepatitisHost Resistance in Liver Disease — Its Evaluation and Therapeutic ModificationViral Hepatitis, Type BHaemodialysis: A Historical ReviewGeneral introduction — historical reviewHepatitis B surface antigen in the liver and serum of patients with hepatitisReferencesViral hepatitis: Epidemiologic, serologic and clinical manifestationsClinical, Epidemiological and Prognostic Aspects of Hepatitis A, B and "Non-A, Non-B"T-lymphocytes and hepatitis B serologyT AND B LYPMHOCYTE SUBPOPULATIONS IN DOWN'S SYNDROME. A STUDY ON NON-INSTITUTIONALISED SUBJECTSSERUM VITAMIN A AND CAROTENE LEVELS IN DOWN'S SYNDROME AND OTHER RETARDED SUBJECTS SHOWING ENAMEL ABNORMALITIES OF THE PERMANENT DENTITIONThe genetic hypothesis for the transmission of Australia antigen (HBsAg)Viral Hepatitis in General Hospitals: Guidelines for Control and PreventionHepatitis viruses and vaccinesLiver disease in renal transplant recipientsCytologic localization of virus antigens and the role of the immune responseImmune Mechanisms and the Action of Interferon in Chronic Hepatitis B Virus InfectionImmunological Abnormalities Associated with liver Disease: Cause or Effect?Australia Antigen and the Biology of Hepatitis BRecent advances in the identification of hepatitis virusesTissue Antigens: Autoantigens, Ailoantigens, Xenoantigens and Neoantigens*VITAMIN A AND CAROTENE VALUES OF INSTITUTIONALISED MENTALLY RETARDED SUBJECTS WITH AND WITHOUT DOWN'S SYNDROMEImmunodeficiency in Down's syndrome: Relationship between presence of human thyroglobulin antibodies and HBsAg carrier statusThe Virus of Hepatitis, Type BHepatitisPrimary liver cell carcinoma in the presence or absence of hepatitis b antigenIncidence and Distribution of Hepatitis B s -Antigen in TurkeyIMMUNISATION AGAINST HEPATITIS B IN MANPlasma FractionationBlood Transfusion and Transmissible DiseaseDistribution patterns of hepatitis B surface antigen (HBsAg) in the liver of hepatitis patients.Viral HepatitisSurveillance and SeroepidemiologyLiver Disease Due to Infection and AllergyVirologie der menschlichen HepatitisAetiological factors in immune-mediated liver diseaseHEPATITIS B VIRUS: A CAUSE OF PERSISTENT VIRUS INFECTION IN MANHepatitis in PrimatesHepatitis-Associated (Australia) Antigen and Down's SyndromePrevention of Nosocomial Viral Hepatitis, Type B (Hepatitis B)DAVID R. SNYDMAN, M.D., JOHN A. BRYAN, M.D., RICHARD E. DIXON, M.D.IMPACT OF AUSTRALIA ANTIGEN (HB s Ag) ON HEPATITISFoodhandler-Associated Outbreak of Hepatitis Type A An Immune Electron Microscopic StudyJULES L. DIENSTAG, M.D., JOHN A. ROUTENBERG, ROBERT H. PURCELL, M.D., RICHARD R. HOOPER, WILLIAM O. HARRISONThe incidence and significance of hepatitis B (surface) antibody in a burns unitINTEGRATOR ENZYME HYPOTHESIS FOR REPLICATION OF HEPATITIS-B VIRUSHepatitis B antigens in serum and liver of chimpanzees acutely infected with hepatitis B virusIsolation of hepatitis B surface antigen (HBsAg) by affinity chromatography on antibody-coated immunoadsorbentsHepatitis associated antigen and the ABO locus in Down's syndromeViral hepatitis in drug addictsThe multiple aetiology of viral hepatitisA review of the present position of Australia antigenSerial Studies of Hepatitis-Associated Antigen and Antibody in Patients Receiving Antitumor Chemotherapy for Myeloproliferative and Lymphoproliferative DisordersViral hepatitisAntígeno da hepatite B na síndrome de DownElevated Serum Iron Levels and Persistent Australia Antigen (HBSAg)ALTON I. SUTNICK, M.D., F.A.C.P., BARUCH S. BLUMBERG, M.D., D. PHIL., F.A.C.P., EDWARD D. LUSTBADER, PH.D.Immunologic reactions and Australia Antigenemia in Down's SyndromePost-transfusion hepatitis in a London hospital: results of a two-year prospective studySubtype and Transmission of Hepatitis B Virus in two Closed InstitutionsHepatitis A and BCell-mediated immune response to hepatitis B antigen in patients with liver diseaseLeukocyte function in Down's syndrome quantitative NBT reduction and bactericidal capacityPRECIPITATING ANTIBODIES IN THE SERA OF TRANSFUSED PATIENTS: POSSIBLE CONFUSION WITH ANTI-AUHepatitis Carriers Among Soldiers Who Have Returned from Vietnam. Australia Antigen StudiesHepatitis A: Detection by Immune Electron Microscopy of a Viruslike Antigen Associated with Acute IllnessCellul�re Immunreaktionen gegen�ber dem Hepatitisassoziierten Antigen (HAA) und homologem leberspezifischen Protein (HLP) bei akuten HAA-positiven HepatitidenChronische Virushepatitis im KindesalterDNA Polymerase Associated with Human Hepatitis B AntigenThe Emerging Epidemiology of Hepatitis B AntigenC. E. CHERUBIN, M.D., W. SZMUNESS, M.D.A simple procedure for purification of Hepatitis B-antigenSIMILARITY OF HEPATITIS FOLLOWING TRANSFUSION OF AUSTRALIA-ANTIGEN POSITIVE AND NEGATIVE BLOODNew Determinants of Hepatitis B Antigen (Au or HB Antigen)Detection of virus antigens: Hepatitis B antigenAustralia Antigen: Progress ReportANENCEPHALY AND OVULATION STIMULATIONHEPATITIS-ASSOCIATED ANTIGEN AND BURKITT'S LYMPHOMALOCALISATION OF PARATHYROID TUMOURSIMMUNOTHERAPY FOR AUSTRALIA-ANTIGEN-ASSOCIATED HEPATOMATHE PROBLEM OF VIRAL HEPATITIS IN A RESIDENTIAL INSTITUTIONPrefaceA possible relationship to treatment between hepatitis-associated antigen and chronic persistent hepatitis in Hodgkin's diseaseRecherche de l'antigène Australia dans 230 cas d'hépatite virale et 190 cas d'affections diversesSerum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver diseaseAustralia antigen and primary biliary cirrhosisEvaluation of a Red Cell Agglutination Test for Detection of Australia Antigen (HB Ag)Immunopathog0enesis of Chronic Hepatitis: A Review*New faces of viral hepatitisAn approach to the management of viral hepatitis in a residential institutionAustralia antigen and Down's syndromeAustralia Antigen in Active Chronic Hepatitis in Australia: Results in 130 Patients from three Centres*Australia Antigen (Hepatitis-Associated Antigen)The anesthesiologist's legal responsibilities in blood transfusionsA Fetal Antigen Associated with Human NeoplasiaHIGH‐VOLTAGE IMMUNOELECTROOSMOPHORESIS IN AUSTRALIA ANTIGEN SCREENING OF BLOOD DONORSCELLULAR IMMUNITY AND HEPATITIS-ASSOCIATED, AUSTRALIA ANTIGEN LIVER DISEASEAn Appraisal of Genetic Studies on LeprosyLong-incubation (virus B, HAA-associated) hepatitis.Etiology and pathogenesis of rheumatoid arthritis and related multisystem diseasesHepatitis-assoziiertes Antigen (HAA): Klinische und immunologische BedeutungImmunpathogenese chronisch-entzündlicher LebererkrankungenAustralia Antigen, an Antigen Associated with Viral HepatitisAustralia-Antigen bei Neugeborenen, S�uglingen und KleinkindernABORTION ON DEMANDAUSTRALIA ANTIGEN AND DOWN'S SYNDROMEIII.—New Developments in Large-scale Plasma FractionationV.—Principles of Effective and Safe TransfusionRecovery of Australia Antigen from Human Plasma Products Separated by a Modified Cohn FractionationThe Australia (hepatitis-associated) antigen amongst heroin addicts attending a London addiction clinicPractical Applications of the Australia Antigen TestHEPATITIS AND HEPATITIS ASSOCIATED ANTIGEN (HAA) IN DOWN'S SYNDROMESerum Hepatitis in Swedish Track-FindersHepatitis-Associated Antigen and Hepatocellular Carcinoma in TaiwanMYRON J. TONG, M.D., Ph.D., SHIH-CHIEN SUN, M.D., BERTON T. SCHAEFFER, M.D., NAI-KWEI CHANG, M.D., KWANG-JUEI LO, M.D., ROBERT L. PETERS, M.D.Eine sensible Komplementbindungsreaktion (KBR) zum Nachweis des Au/SH-Antigens und ihr Vergleich mit dem Agargeltest und der GegenstromelektrophoreseHepatitis-associated antigen in urban childrenSH (Australia) antigen in early lifeCollagen Disease Debuting as Acute HepatitisANICTERIC VIRAL HEPATITIS IN BLOOD DONORS: A CUNICO–PATHOLOGICAL AND AUSTRALIA ANTIGEN STUDY IN SINGAPOREAustralia antigen and antibody and alpha-fetoglobulin in hepatoma patientsHepatocellular carcinoma, positive Australia (hepatitis-associated) antigen and sarcoidosisTHYROID ANTIBODIES AND AUSTRALIA ANTIGEN IN DOWN'S SYNDROMERELATIONSHIP OF HEPATITIS-ASSOCIATED ANTIGEN (H.A.A.) TO ACUTE AND CHRONIC LIVER INJURYGLOMERULONEPHRITIS WITH DEPOSITION OF AUSTRALIA ANTIGEN-ANTIBODY COMPLEXES IN GLOMERULAR BASEMENT MEMBRANEErgasteric Hepatitis: Endemic Hepatitis Associated with Australia Antigen in a Research LaboratoryALTON I. SUTNICK, M.D., F.A.C.P., W. THOMAS LONDON, M.D., F.A.C.P., IRVING MILLMAN, Ph.D., BETTY JANE S. GERSTLEY, M.D., F.A.C.P., BARUCH S. BLUMBERG, M.D., Ph.D., F.A.C.P.FREQUENCY OF AUSTRALIA ANTIGEN IN PATIENTS WITH LEUKÆMIA IN DIFFERENT COUNTRIESAustralia Antigen: Large-Scale Purification from Human Serum and Biochemical Studies of Its ProteinsTHE INCIDENCE OF AUSTRALIA ANTIGEN IN BLOOD DONORS AND IN CERTAIN HIGH–RISK PATIENT POPULATIONSSensitive Matrix Gel Diffusion Test for the Detection of Australia AntigenSpecific Antibody Response after Transfusion of Australia Antigen-Positive Blood in a Patient with Liver CirrhosisOCCURRENCE OF AUSTRALIA ANTIGEN IN PATIENTS WITH DOWN'S SYNDROME IN POLAND*A Simple Method for Preparation of Anti-Australia Antigen SerumAustralia Antigen in Liver Disease [ Abridged ]Familial Hepatoma with Hepatitis-Associated AntigenEDWARD K. DENISON, M.D., ROBERT L. PETERS, M.D., TELFER B. REYNOLDS, M.D., F.A.C.P.Diagnostic VirologyThe Australia (hepatitis-associated) antigen in fibrinogen and other fractions of human plasmaNeue Gesichtspunkte bei der Verhütung der transfusionsbedingten Serumhepatitis (Au/SH-Antigen)Reactions of Viruses in Agar GelTHE AUSTRALIA ANTIGEN IN AUTO-IMMUNE LIVER DISEASEL'antigène Australia mise en évidence, spécificité, intérêt pratiqueRNA of Australia AntigenAustralia Antigen and Hepatitis: A Comprehensive ReviewLepromatous leprosy and australia antigen with comments on the genetics of leprosyDISTINCTIONS IN CHRONIC ACTIVE HEPATITIS BASED ON CIRCULATING HEPATITIS-ASSOCIATED ANTIGENHEPATITIS-ASSOCIATED ANTIGEN AND CIRRHOSIS IN UGANDAFrequency of the Australia-SH Antigen and Antibody among Norwegian Blood DonorsAUSTRALIA ANTIGEN IN PATIENTS WITH VARIOUS LIVER DISEASESDetection of Serum Hepatitis Virus Carriers by Testing for the SH (Australia) AntigenCo-occurrence of anti-Ag and anti-Australia Antibodies in Transfused PatientsAustralia antigen and primary liver cancerHepatitis-associated antigenLEVODOPA AND MIGRAINEAUSTRALIA (HEPATITIS) ANTIGEN IN SARCOIDOSISA "VIRUS" ASSOCIATED WITH SERUM HEPATITISStudies in Down's SyndromeA Conceptual Basis of Viral HepatitisExperiences on Australia Antigen in ItalyHEPATITIS-ASSOCIATED ANTIGEN IN UGANDAN PATIENTS WITH HEPATOCELLULAR CARCINOMAAUSTRALIA ANTIGEN, HEPATITIS VIRUS AND DOWNS SYNDROMEHepatitisAUSTRALIA ANTIGEN AND VIRAL HEPATITIS IN SYDNEY: A HOSPITAL SERIESAustralia Antigen and HepatitisDIFFERENT AUSTRALIA-ANTIGEN DETERMINANTS IN ACUTE VIRAL HEPATITISSERUM HEPATITIS AND THE AUSTRALIA ANTIGENPrecipitating factors against chicken proteins in patients with Down's syndromeAN ANTIGEN CLOSELY RELATED TO THE AUSTRALIA-SH ANTIGEN IN THE SERUM OF AN APPARENTLY HEALTHY BLOOD DONORAustralia Antigen in a Closed Adult Population Monitored for Serum Glutamic Oxalacetic TransaminaseAn Unusual Form of Diabetes Mellitus in Ataxia TelangiectasiaPreoperative Preparation of the Jaundiced Patient: A Review of Current PracticePLASMA, ERYTHROCYTE AND LEUCOCYTE ZINC LEVELS IN DOWN'S SYNDROMEAntibody Responses to the Epstein–Barr Virus and Cytomegaloviruses after Open-Heart and Other SurgeryViral Hepatitis: Revised Concepts as a Result of the Study of Australia AntigenTHE AUSTRALIA ANTIGEN AND VIRAL HEPATITISImmunologic Distinction between Infectious and Serum HepatitisAustralia Antigen, Transfusion and HepatitisAdaptation to infectious disease. Australia antigen and hepatitisViral HepatitisCELLULAR LOCALISATION OF AUSTRALIA ANTIGEN IN THE LIVER OF PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERSFailure to detect an Antigen associated with Hepatitis in a Community EpidemicProgress report: hepatitis-associated (Australia) antigen.The Australia antigen in Brazilian healthy persons and in leprosy and leukaemia patientsViral HepatitisN. RAPHAEL SHULMAN, M.D., RICHARD J. HIRSCHMAN, M.D., LEWELLYS F. BARKER, M.D.Australia antigen as a hepatitis virusAustralia (Hepatitis-Associated) Antigen: Physicochemical And Immunological CharacteristicsGenesis of HepatitisThe Geographical Pathology of Liver Disease in ManBiophysical Properties of Australia AntigenTelevision scanning of cervical smears: the quantimet.Laboratory tests in viral hepatitis.An Epidemic of Hepatitis in a Chronic-Hemodialysis UnitHepatitis VirusAUSTRALIA ANTIGEN IN CHRONIC ACTIVE LIVER DISEASE WITH CIRRHOSISViral Hepatitis and the Australia-SH AntigenAUSTRALIA ANTIGEN IN ACUTE AND CHRONIC LIVER DISEASES.H. ANTIGEN IN HÆMODIALYSIS-ASSOCIATED HEPATITISAustralia Antigen and HepatitisPersistence of the Serum Hepatitis (SH-Australia) Antigen for Many YearsPRESENCE AND PERSISTENCE OF AUSTRALIAN ANTIGEN IN A SWEDISH HEPATITIS SERIESHEPATITIS ANTIGENAustralia Antigen detected in the Nuclei of Liver Cells of Patients with Viral Hepatitis by the Fluorescent Antibody TechniqueRelation between SH and Australia AntigensAustralia antigen and the quest for a hepatitis virusViral hepatitis in subhuman primates and its relationship to human viral hepatitisAntigène et anticorps des hépatites à virusAdditional Specificities of Australia Antigen and the Possible Identification of Hepatitis CarriersAustralia Antigen and Acute Viral HepatitisW. THOMAS LONDON, M.D., F.A.C.P., ALTON I. SUTNICK, M.D., F.A.C.P., BARUCH S. BLUMBERG, M.D., F.A.C.P.Australia-SH AntigenObservations on Australia Antigen in JapaneseWHAT'S IN P.V.C.?RELATION OF AUSTRALIA AND SH ANTIGENSA NEW PRECIPITATING ANTIGEN-ANTIBODY SYSTEM (PENNSYLVANIA ANTIGEN) IN HUMAN SERUMParticles associated with Australia Antigen in the Sera of Patients with Leukaemia, Down's Syndrome and HepatitisSERUM-PROTEINS IN DOWN'S SYNDROMEASSOCIATION BETWEEN LEPROMATOUS LEPROSY AND AUSTRALIA ANTIGEN 1 May 1967Volume 66, Issue 5Page: 924-931KeywordsAntigensHemophiliaHepatitis AHepatitis EHepatitis E virusLow density lipoproteinPopulation statisticsProteinsResearch grantsResearch laboratories ePublished: 1 December 2008 Issue Published: 1 May 1967 PDF downloadLoading ...